NIMS NEPAL

NIMS NEPAL Detail informations of drugs in Nepal . NIMS Dealing with drugs since 2010 , we publish and gives information about Drugs In Nepal .

Aripiprazole shortage
02/09/2022

Aripiprazole shortage

The Department of Health says some strengths of the anti-psychotic drug remain available.

11/08/2022

BENZODIAZEPAMS:
Lorazepam, Diazepam , Chlordizepoxide withdrawal symptoms may be even worse then the condition for which drug was prescribed.

25/07/2022

Exenatide must be given by subcutaneous injection within 60 minutes before the morning and evening meals. It should not be given after a meal.

Liraglutide is the other GLP-1 mimetic currently available. One the main advantages of liraglutide over exenatide is that it only needs to be given once a day.

  3
22/08/2021

3

19/08/2021

Carbamazepine is a well-recognised cause of hyponatraemia, which occurs in a dose-related manner and is reversible after drug cessation.

Pharmacology Classifications :
17/08/2021

Pharmacology Classifications :

Carbapenemase producing enterobacteriaceae (CPE) are multi-drug resistant coliforms. They can be treated with polymyxins...
17/04/2021

Carbapenemase producing enterobacteriaceae (CPE) are multi-drug resistant coliforms.
They can be treated with polymyxins (e.g. colistin), tigecycline, fosfomycin or aminoglycosides (e.g. gentamicin)

04/01/2021

Cyclin-dependent kinase (CDK) 4/6 pathway inhibitors
*Palbociclib, Ribociclib, Abemaciclib
*Breast cancer, especially ER+, HER2 -
*Used with aromatase inhibitors

07/12/2020

Patients with MI secondary to co***ne use should be given IV benzodiazepines as part of acute (ACS) treatment

Address

Putalisadak
Kathmandu

Website

Alerts

Be the first to know and let us send you an email when NIMS NEPAL posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to NIMS NEPAL:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram